Ace Alzheimer Center Barcelona. Universitat Internacional de Catalunya
Memory Unit and Research Center
• Neurologist and PhD (Universitat de Barcelona). • Founder and medical director of ACE Alzheimer Center Barcelona. • Distinguished professor of Universitat Internacional de Catalunya. • Member of the Executive Committee of the European Alzheimer’s disease Consortium. • Linked to the Vall d'Hebrón University Hospital, where she did her professional training in the neurology unit as clinical chief. • Head of the dementia research unit of the Vall d’Hebrón Research Institute. She has participated in different European projects, such as EPAD (European Prevention of Alzheimer’s Dementia Consortium), AMYPAD (Amyloid Imaging to Prevent Alzheimer’s disease) and PreDADQoL, being the project leader of MOPEAD (IMI-Innovative Medicines Initiative) She has participated as a collaborating consultant for the pharmaceutical industry in Alzheimer's disease studies. She has led more than 135 international clinical trials on AD and other dementias and published more than 280 articles, 37 book chapters and 12 medical outreach books. Furthermore, she is a member of the Editorial Board of “Journal of Prevention of Alzheimer’s Disease” and “Journal of Alzheimer’s Disease” magazines. In 2016, she was awarded with the Creu de Sant Jordi for her contribution to research in the field of dementias and particularly Alzheimer's disease. This is one of the highest recognitions that a Catalonian citizen can receive from the Catalan government.

Moderator of 2 Sessions

SPONSORED SYMPOSIUM
Session Type
SPONSORED SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE PLENARY: 115-117
Session Description
Novel approaches in AD: Cutting Edge Science, Diagnostic and Therapeutic Strategies-Supported by Grifols .

Session Description:

Alzheimer’s Disease is a multifactorial disorder, yet therapeutic focus is often limited to specific pathways. This session will expand thinking to how multiple mechanisms acting in parallel can be understood, approached and targeted to deliver accurate diagnosis tools and impactful therapies. Through basic science to uncover systemic influences on the brain, cutting edge biomarkers to assess a plethora of mechanisms and innovative approaches now being used in the clinic, we are reaching reality in harnessing this multimodality. This fresh perspective in approaches to AD diagnosis and therapeutic development builds on decades of research in the field, giving birth to accurate biomarkers and eventually to new generation therapies.

Session Type
SYMPOSIUM
Date
Sat, 19.03.2022
Session Time
02:45 PM - 04:45 PM
Room
ONSITE: 114

Presenter of 3 Presentations

Discussion

Session Type
SPONSORED SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE PLENARY: 115-117
Lecture Time
10:55 AM - 11:10 AM

Where does our hope come from in Alzheimer’s disease?

Session Type
SPONSORED SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
12:15 PM - 01:25 PM
Room
ONSITE: 113
Lecture Time
12:15 PM - 01:25 PM

Welcome and introduction

Session Type
SPONSORED SYMPOSIUM
Date
Fri, 18.03.2022
Session Time
09:10 AM - 11:10 AM
Room
ONSITE PLENARY: 115-117
Lecture Time
09:10 AM - 09:15 AM